Artificial liver device shows promise in early safety trial
Disease control
Completed
This early-stage study tested a device called miroliverELAP in 10 adults with sudden liver failure. The device acts like an external liver, filtering blood for up to 48 hours to give the liver time to heal or to bridge patients to a transplant. The main goal was to check safety a…
Phase: PHASE1 • Sponsor: Miromatrix Medical Inc. • Aim: Disease control
Last updated May 13, 2026 16:01 UTC